Advertisement

Biological Tests in the Diagnosis and Treatment of Affective Disorders

  • Harvey A. Sternbach
  • Harry E. Gwirtsman
  • Robert H. Gerner

Abstract

Psychiatry has traditionally been distanced by other branches of medicine because it lacked means whereby diagnoses and treatments could be arrived at objectively. Other specialties of medicine can turn to diagnostic aids through which differential diagnoses can be narrowed down and specific treatments instituted. Over the last 10 years psychiatry has been seeking and discovering its own diagnostic aids and classification schemes to similarly enable psychiatrists to narrow their differential diagnoses and initiate specific treatments. The affective disorders have received a large share of attention, and rightfully so, since a large segment of the population in this country will experience a major depressive episode at some time in their lives (Katz, 1980). This chapter will focus on several currently existing biological tests used to assess affective disorders and the relationships of these tests to one another and response to treatment. Our intention is to provide the reader with a brief review of each test followed by a discussion of findings from the authors’ own investigations examining the relationships of these tests and treatment response. The implications of our findings, as well as those of others, will be discussed in light of current theories of the etiology of affective disorders and mechanisms underlying response to treatment.

Keywords

Dexamethasone Suppression Test Unipolar Depressive Positive Treatment Response Noradrenergic Agent Urine MHPG 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beckmann, H., and Goodwin, F. K., 1975, Antidepressant response to tricyclics and urinary MHPG in unipolar patients: Clinical response to imipramine or amitriptyline, Arch. Gen. Psychiatry 32:17.PubMedCrossRefGoogle Scholar
  2. Berens, S. C., Bernstein, R. S., Robbins, J., and Wolff, J., 1970, Antithyroid effects of lithium, J. Clin. Invest. 49:1357.PubMedCrossRefGoogle Scholar
  3. Besses, G. S., Burrow, G. N., Spaulding, S. W., and Donebedian, R. K., 1975, Dopamine infusion acutely inhibits the TSH and prolactin response to TRH, J. Clin. Endocrinol. Metab. 41:985.PubMedCrossRefGoogle Scholar
  4. Blombery, P. A., Kopin, I. J., Gordon, E. K., Markey, S. P., and Ebert, M. H., 1980, Conversion of MHPG to vanillylmandelic acid: Implications for the importance of urinary MHPG, Arch. Gen. Psychiatry 37:1095.PubMedCrossRefGoogle Scholar
  5. Brown, W. A., 1977, Psychologic and neuroendocrine response to methylphenidate, Arch. Gen. Psychiatry 34:1103.PubMedCrossRefGoogle Scholar
  6. Brown, W. A., Haier, R. J., and Quails, C. B., 1981, The dexamethasone suppression test in the identification of subtypes of depression differentially responsive to antidepressants, Psycho- pharmacol. Bull. 17:88.Google Scholar
  7. Bunney, W. E., Jr., and Davis, J. M., 1965, Norepinephrine in depressive reactions, Arch. Gen. Psychiatry 13:483.PubMedCrossRefGoogle Scholar
  8. Carroll, B. J., 1978, Neuroendocrine function in psychiatric disorders, in: Psychopharmacology: A Generation of Progress (M. A. Lipton, A. DiMascio, and K. F. Killam, eds.), pp. 487–498, Raven Press, New York.Google Scholar
  9. Carroll, B. J., Curtis, G. C., and Mendels, J., 1976, Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction, Arch. Gen. Psychiatry 33:1039.PubMedCrossRefGoogle Scholar
  10. Carroll, B. J., Feinberg, M., Greden, J. F., Tarika, J., Albala, A. A., Haskett, R. F., James, N. M., Kronfol, Z., Lohr, N., Steiner, M., de Vigne, J. P., and Young, E., 1981, A specific laboratory test for diagnosis of melancholia, Arch. Gen. Psychiatry 38:15.PubMedCrossRefGoogle Scholar
  11. Checkley, S. A., Slade, A. P., Shur, E., and Dawling, S., 1981, A pilot study of the mechanism of action of desipramine, Br. J. Psychiatry 138:248.PubMedCrossRefGoogle Scholar
  12. Cohen, R. M., Campbell, I. C., Cohen, M. R., Torda, T., Pickar, D., Siever, L. J., and Murphy, D. L., 1980, Presynaptic noradrenergic regulation during depression and antidepressant drug treatment, Psychiatry Res. 3:93.PubMedCrossRefGoogle Scholar
  13. Dekirmenjian, H., 1981, National Psychopharmacology Laboratory, Knoxville, Tenn.Google Scholar
  14. Dekirmenjian, H., and Maas, J. W., 1970, An improves procedure of 3-methoxy-4-hydroxyphenyl-ethylene glycol determined by gas-liquid chromatography, Anal. Biochem. 35:113.PubMedCrossRefGoogle Scholar
  15. Edwards, D. J., Spiker, D. G., Neil, J. F., Kopfer, D. J., and Rizk, M., 1980, MHPG excretion in depression, Psychiatry Res. 2:295.PubMedCrossRefGoogle Scholar
  16. Extein, I., Pottash, A. L., Gold, M. S., Cadet, J., Sweeney, D. R., Davies, R. K., and Martin, D. M., 1980a, The thyroid-stimulating hormone response to thyrotropin-releasing hormone in mania and bipolar depression, Psychiatry Res. 2:199.PubMedCrossRefGoogle Scholar
  17. Extein, I., Pottash, A. L. C., Gold, M. S., and Martin, D. M., 1980b, Differentiating mania from schizophrenia by the TRH test, Am. J. Psychiatry 137:981.PubMedGoogle Scholar
  18. Extein, I., Pottash, A. L. C., and Gold, M. S., 1981, Relationship of the thyrotropin-releasing hormone test and dexamethasone suppression test abnormalities in unipolar depression, Psychiatry Res. 4:49.PubMedCrossRefGoogle Scholar
  19. Fawcett, J., and Siomopoulos, V., 1971, Dextroamphetamine response as a possible predictor of improvement with tricyclic therapy in depression, Arch. Gen. Psychiatry 25:247.CrossRefGoogle Scholar
  20. Fawcett, J., Maas, J. W., and Dekirmenjian, H., 1972, Depression and MHPG excretion: Response to dextroamphetamine and tricyclic antidepressants, Arch. Gen. Psychiatry 26:246.PubMedCrossRefGoogle Scholar
  21. Ferris, R. M., and Tang, F. L. M., 1979, Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of l-(3H)norepinephrine and (3H)dopamine by synaptic vesicles from rat whole brain, striatum, and hypothalamus, J. Pharmacol. Exp. Ther. 210:422.PubMedGoogle Scholar
  22. Frazer, A., and Mendels, J., 1980, Effects of antidepressant drugs on adrenergic responsiveness and receptors, in: The Psychobiology of Affective Disorders (J. Mendels and J. Amsterdam, eds.), pp. 72–82, Karger, Basel.Google Scholar
  23. Gold, M. S., Pottash, A. L. C., Ryan, N., Sweeney, D. R., Davies, R. K., and Martin, D. M., 1980, TRH-induced TSH response in unipolar, bipolar, and secondary depressions: Possible utility in clinical assessment and differential diagnosis, Psychoneuroendocrinology 5:147.PubMedCrossRefGoogle Scholar
  24. Gold, M. S., Pottash, A. L. C., Extein, I., and Sweeney, D. R., 1981, Diagnosis of depression in the 1980’s, J. Am. Med. Assoc. 245:1562.CrossRefGoogle Scholar
  25. Gold, P. W., Goodwin, F. K., Wehr, T., and Rebar, R., 1977, Pituitary thyrotropin response to thyrotropin-releasing hormone in affective illness: Relationship to spinal fluid amine metab olites, Am. J. Psychiatry 134:1028.PubMedGoogle Scholar
  26. Hershman, J. M., 1980, Control of thyrotropin secretion, in: Radioimmunoassay of Hormones, Proteins and Enzymes (A. Albertini, ed.), pp. 13–22, Excerpta Medica, Amsterdam.Google Scholar
  27. Hollister, L. E., Davis, K. L., Overall, J. E., and Anderson, T., 1978, Excretion of MHPG in normal subjects: Implications for biological classification of affective disorders, Arch. Gen. Psychiatry 35:1410.PubMedCrossRefGoogle Scholar
  28. Hollister, L. E., Davis, K. L., and Berger, P. A., 1980, Subtypes of depression based on excretion of MHPG and response to nortriptyline, Arch. Gen. Psychiatry 37:1107.PubMedCrossRefGoogle Scholar
  29. Kastin, A. J., Ehrensing, R. H., Schalch, D. S., and Anderson, M. S., 1972, Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone, Lancet II:740.CrossRefGoogle Scholar
  30. Katz, M. M., 1980, Depression: A national health problem, in: The Psychobiology of Affective Disorders (J. Mendels and J. D. Amsterdam, eds.), pp. 1–10, Karger, Basel.Google Scholar
  31. Kirkegaard, C., and Carroll, B. J., 1980, Dissociation of TSH and adrenocortical disturbances in endogenous depression, Psychiatry Res. 3:253.PubMedCrossRefGoogle Scholar
  32. Kirkegaard, C., and Smith, E., 1978, Continuing therapy in endogenous depression controlled by changes in the TRH stimulation test, Psychol. Med. 8:501.PubMedCrossRefGoogle Scholar
  33. Kirkegaard, C., Bjørum, N., Cohn, D., Faber, J., Lauridsen, U. B., and Nekup, J., 1977, Studies on the influence of biogenic amines and psychoactive drugs on the prognostic value of the TRH stimulation test in endogenous depression, Psychoneuroendocrinology 2:131.PubMedCrossRefGoogle Scholar
  34. Kirkegaard, C., Faber, J., Hummer, L., and Rogowski, P., 1979, Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression, Psychoneuroendocrinology 4:227.PubMedCrossRefGoogle Scholar
  35. Lauridsen, U. B., Kirkegaard, C., and Nerup, J., 1974, Lithium and the pituitary-thyroid axis in normal subjects, J. Clin. Endocrinol. Metab. 39:383.PubMedCrossRefGoogle Scholar
  36. Loosen, P. T., Prange, A. J., Jr., Wilson, I. C., and Lara, P. O., 1976, Pituitary responses of thyrotropin releasing hormone in depressed patients: A review, Pharmacol. Biochem. Behav. 5:95.PubMedCrossRefGoogle Scholar
  37. Maas, J. W., 1975, Biogenic amines and depression: Biochemical and pharmacological separation of two types of depression, Arch. Gen. Psychiatry 32:1357.PubMedCrossRefGoogle Scholar
  38. Matussek, N., Ackenheil, M., Hippius, H., Müller, R., Schröder, H. T., Schuttes, H., and Wasilewski, B., 1980, Effect of Clonidine on growth-hormone release in psychiatric patients and controls, Psychiatry Res. 2:25.PubMedCrossRefGoogle Scholar
  39. Otsuki, M., Dakoda, M., and Baba, S., 1973, Influence of glucocorticoids on TRH-induced TSH response in man, J. Clin. Endocrinol Metab. 36:95.PubMedCrossRefGoogle Scholar
  40. Prange, A. J. Jr., Wilson, I. C., Lara, P. P., and Alltop, L. B., 1972, Effects on thyrotropin releasing hormone in depression, Lancet II:999.CrossRefGoogle Scholar
  41. Refetoff, S., Frank, P. H., Roubebush, C. P., and DeGroot, L. J., 1979, Clinical endocrine disorders of hypothalamus and pituitary: Evaluation of pituitary function, in: Endocrinology, Vol. 1 (L. J. Degroot, G. F. Cahill Jr., L. Martini, D. H. Nelson, W. D. Odell, J. T. Potts Jr., E. Steinberger, and A. I. Winegrod, eds.), pp. 196–199, Grune & Stratton, New York.Google Scholar
  42. Reichlin, S., 1975, Regulations of the hypophysiotropic secretions of the brain, Arch. Intern. Med. 135:1350.PubMedCrossRefGoogle Scholar
  43. Rogol, A. D., Reeves, G. D., Varma, M. M., and Blizzard, R. M., 1979, Thyroid-stimulating hormone and prolactin responses to thyrotropin-releasing hormone during infusion of epinephrine and propranolol in man, Neuroendocrinology 29:413.PubMedCrossRefGoogle Scholar
  44. Rosenbaum, A. H., Schatzberg, A. F., Maruta, T., Orsulak, P. J., Cole, J. O., Grab, E. L., and Schildkraut, J. J., 1980, MHPG as a predictor of antidepressant response to imipramine and maprotiline, Am. J. Psychiatry 137:1090.PubMedGoogle Scholar
  45. Sachar, E. J., 1975, Twenty-four-hour Cortisol secretory patterns in depressed and manic patients, Prog. Brain Res. 42:81.PubMedCrossRefGoogle Scholar
  46. Sachar, E. J., Asnis, G., Halbreich, U., Nathan, S., and Halpern, F. S., 1980a, Recent studies in the neuroendocrinology of major depressive disorders, in: The Psychiatric Clinics of North America, Vol. 3, No. 2 (E. J. Sachar, ed.), pp. 313–326, Saunders, Philadelphia.Google Scholar
  47. Sachar, E. J., Asnis, G., Nathan, S., Halbreich, U., Tabrizi, M. A., and Halpern, F. S., 1980b, Dextroamphetamine and Cortisol in depression: Morning plasma Cortisol levels suppressed, Arch. Gen. Psychiatry 37:755.PubMedCrossRefGoogle Scholar
  48. Schatzberg, A. F., Orsulak, P. J., Rosenbaum, A. H., Kruger, E. R., Schildkraut, J. J., and Cole, J. O., 1980, Catecholamine measures for diagnosis and treatment of patients with depressive disorders, J. Clin. Psychiatry 41:35.PubMedGoogle Scholar
  49. Schildkraut, J. J., 1965, The catecholamine hypothesis of affective disorders: A review of supporting evidence, Am. J. Psychiatry 122:509.PubMedGoogle Scholar
  50. Schlesser, M. A., Winokur, G., and Sherman, B. M., 1980, Hypothalamic-pituitary-adrenal axis activity in depressive illness: Its relationship to classification, Arch. Gen. Psychiatry 31:131.Google Scholar
  51. Snyder, P. J., and Utiger, R. D., 1972, Thyrotropin response to thyrotropin releasing hormone in normal females over forty, J. Clin. Endocrinol. Metab. 34:1096.PubMedCrossRefGoogle Scholar
  52. Sulser, F., 1978, Functional aspects of the norepinephrine receptor-coupled adenylate cyclase system in the limbic forebrain and its modification by drugs which precipitate or alleviate depression: Molecular approaches to an understanding of affective disorders, Pharmakop- sychiatr. Neuro-Psychopharmakol. 11:43.Google Scholar
  53. Sweeney, D. R., Maas, J. W., and Heninger, G. R., 1978, State anxiety, physical activity, and urinary 3-methoxy-4-hydroxyphenethylene glycol excretion, Arch. Gen. Psychiatry 35:1418.PubMedCrossRefGoogle Scholar
  54. Van Kammen, D. P., and Murphy, D. L., 1978, Prediction of imipramine antidepressant response by a one day d-amphetamine trial, Am. J. Psychiatry 135:1179.PubMedGoogle Scholar
  55. Weinstein, R., 1978, Deciding which antidepressant to use, Am. J. Psychiatry 135:620.PubMedGoogle Scholar
  56. Woolf, P. D., Lee, L. A., and Schalch, D. S., 1972, Adrenergic manipulations and TRH-induced thyrotropin (TSH) release, J. Clin. Endocrinol. Metab. 35:616.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1984

Authors and Affiliations

  • Harvey A. Sternbach
    • 1
    • 2
  • Harry E. Gwirtsman
    • 3
  • Robert H. Gerner
    • 4
    • 5
  1. 1.Department of Psychiatry, Neuropsychiatric InstituteUniversity of California at Los AngelesLos AngelesUSA
  2. 2.Department of PsychiatryBrentwood Veterans Administration HospitalLos AngelesUSA
  3. 3.National Institutes of HealthBethesdaUSA
  4. 4.University of CaliforniaIrvineUSA
  5. 5.Long Beach Veterans Administration HospitalLong BeachUSA

Personalised recommendations